CAS: 329214-79-1; 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Pyridine

相似化合物

1692-25-7 265664-63-9 1171891-42-1

上下游产品

CAS号626-60-8 3-氯吡啶 | CAS号73183-34-3 双戊酰二硼 | CAS号76-09-5 频哪醇 | CAS号160688-99-3 TRIS(3-PYRIDYL)... | CAS号462-08-8 3-氨基吡啶 | CAS号110-86-1 吡啶 | CAS号626-55-1 3-溴吡啶 | CAS号1692-25-7 吡啶-3-硼酸 | CAS号1099598-09-0 3-(2,2,2-Triflu... | CAS号4373-67-5 3-(3-甲氧基苯基)吡啶 | CAS号189193-21-3 3-naphthalen-1-... | CAS号295800-01-0 6-pyridin-3-yl-... | CAS号581-46-4 3,3'-联吡啶 | CAS号581-50-0 2,3'-联吡啶 | CAS号157402-43-2 3-(2,6-dimethyl... | CAS号1008-88-4 3-苯基吡啶 | CAS号1214326-04-1 2-METHYL-3,3 -B... | CAS号13238-38-5 3-苯基乙炔吡啶

在 吡啶,2,6-二叔丁基-4-甲基苯酚,Potassium Carbonate,2-(4,5-二氢-4,4-二甲基-2-恶唑基)吡啶,四(3,5-二(三氟甲基)苯基)硼酸钠,三[3,4-双(三氟甲基)苯基]膦,Palladium Dichloride体系中,用 二氯甲烷,1,2-二氯乙烷 用作溶剂,化学反应 12.0H,反应生成3-吡啶硼酸频哪醇酯
参考文献:通过配体促进的cc键活化来转化芳基酮.
标题:通过配体促进的cc键活化来转化芳基酮.
摘要:芳族亲电试剂(芳基卤化物,芳基醚,芳基酸,芳基腈等)与亲核试剂的偶联是合成芳基化合物的核心方法.由于芳基酮的丰度,通过碳-碳键活化以类似方式进行芳基酮的转化可大大扩展合成芳基化合物的工具箱.这种方法的探索性研究通常基于环应变释放和螯合辅助引发的碳-碳裂解,并且产物也仅限于特定的结构基序.在这里,我们报告了一种配体促进β-碳消除的策略,以激活碳-碳键,这导致芳基酮发生一系列转化,从而生成有用的芳基硼酸酯,以及联芳基,芳基腈和芳基烯烃.吡啶-恶唑啉配体的使用对于这种催化转化至关重要.据报道,通过简单的一锅操作,芳基酮的克级硼酸酯化反应.该策略的潜在效用还通过丙磺舒,阿达帕林和脱氧雌酮,芬芳类香囊素和载脂蛋白的天然产物的晚期药物分子多样化而得到证明.
Doi:10.1002/anie.202006740

专利信息

专利号:WO-2021019559-A1
优先权日:2019-07-30
标题 :Synthesis of 5-(3-pyridyl)-2,2'-bithiophene(sensitizer)
发明人：DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; PRABHU MANOJKUMAR SADANAND; KADAM SACHIN VASANT
权利人:FERMENTA BIOTECH LTD
摘要:Disclosed herein is a novel simple, short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene.

专利号:WO-2023091726-A1
优先权日:2021-11-18
标题:Inhibitors of cyclin‑dependent kinase 12 (cdk12)
发明人：BENOIT GUILLAUME; CARULLI JOHN; CHEN FEI; CHUAQUI CLAUDIO; CIBLAT STEPHANE; COOPER ELLIOT; DAGENAIS ROBIN; HU SHANHU; KABRO ANZHELIKA; LAPLACA DEREK; MARINEAU JASON; MOEBIUS DAVID; MOON DIANE; SOLODININ ANDREI; WHITMORE KENNETH
权利人:SYROS PHARMACEUTICALS INC
摘要:The present invention provides chemical compounds that inhibit one or more families of kinases (e.g., serine/threonine kinases, including one or more of the families of CDK proteins, and in particular, CDK12). More specifically, the present invention provides CDK12 inhibitors, of formula (I), pharmaceutically acceptable salts and isotopically labeled derivatives thereof, pharmaceutical compositions containing the compounds/inhibitors, and methods of their synthesis and use in treating proliferative diseases (e.g., a bladder cancer, a breast cancer, Ewing's sarcoma, a gastric cancer, a gastrointestinal cancer, a hematologic cancer, a lung cancer (e.g., small cell lung cancer (SCLC)), an ovarian cancer (e.g., a high grade serous ovarian cancer), a pancreatic cancer (e.g., pancreatic ductal adenocarcinoma (PDAC)), a brain cancer (e.g., glioblastoma), or a prostate cancer), alone or in combination with a second therapeutic agent. The proliferative disease can be a cancer, benign neoplasm, or pathologic angiogenesis, and any of the therapeutic methods or uses described herein can include a step of diagnosing the patient's disease. In other embodiments of the invention, the compositions described herein (e.g., the compounds, pharmaceutical compositions, and kits containing them) are used for the treatment of myotonic dystrophy (type 1 or type 2).

专利号:CN-104211723-B
优先权日:2014-08-07
标 题 :The synthesis of vinyl borating agent and application

专利号:US-7541367-B2
优先权日:2005-05-31
标 题 :3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
发明人：CHIU GEORGE; CONNOLLY PETER J; EMANUEL STUART; HUANG SHENLIN; LI SHENGJIAN; LIN RONGHUI; LU YANHUA; MIDDLETON STEVEN A
权利人:JANSSEN PHARMACEUTICA NV
摘要:The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I): n nand pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of serine-threonine protein kinases and tyrosine protein kinases and interactions thereof.

专利号:CN-104211723-A
优先权日:2014-08-07
标题 :Synthesis and Application of New Vinylboration Reagents